Spirit 2: Final 5 Year Analysis of the UK National Cancer Research Institute Randomized Study Comparing Imatinib with Dasatinib in Patients with Newly Diagnosed Chronic Phase CML von O'Brien, Stephen, Cork, Leanne, Bandeira, Valeria, Bescoby, Ruth, Foroni, Letizia, Alaily, Lynn, Osborne, Wendy, Bell-Gorrod, Helen, Latimer, Nicholas, Apperley, Jane, Hedgley, Corinne, Syzdlo, Richard, Byrne, Jennifer, Pocock, Christopher, Ramsahoye, Bernard, Zwingers, Thomas, Wason, James, Copland, Mhairi, Clark, Richard

Volltext

Assessment of Quality of Life in the NCRI Spirit 2 Study Comparing Imatinib with Dasatinib in Patients with Newly-Diagnosed Chronic Phase Chronic Myeloid Leukaemia von Labeit, Alexander M., Copland, Mhairi, Cork, Leanne M., Hedgley, Corinne A., Foroni, Letizia, Osborne, Wendy L., Gills, Gemma, Apperley, Jane F., Holyoake, Tessa L., Bescoby, Ruth V., Pocock, Christopher, Zwingers, Thomas, Burnell, Philippa, Byrne, Jenny L., McCullough, John H., Goldman, John M., Clark, Richard E., O'Brien, Stephen G.

Volltext